An approval decision would change the market because it could create the first approved injectable combination of a GLP-1 receptor agonist and an amylin analogue for weight management
On April 30, 2026, the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - which would eliminate the remaining legal pathway for 503B outsourcing facilities to compound these medications in bulk
Hydration Ask about: Persistent vomiting or diarrhea Dizziness or orthostatic symptoms Reduced fluid intake Dark or infrequent urine Fatigue that may reflect inadequate intake Difficulty maintaining hydration during exercise or hot weather Hydration concerns matter especially in patients with kidney disease, cardiovascular disease, diuretic use, or significant gastrointestinal adverse effects
Whilst Ozempic is not an approved treatment for addiction, your doctor can: Assess whether you might benefit from evidence-based addiction treatments, such as psychological therapies, support groups, or medications specifically licensed for substance use disorders (such as acamprosate, naltrexone or disulfiram for alcohol dependence) Refer you to specialist NHS alcohol or drug services if appropriate Discuss smoking cessation services and support if relevant Discuss whether Ozempic might be suitable for you if you also have type 2 diabetes Monitor you carefully if Ozempic is prescribed, watching for both intended effects and any unexpected changes in behaviour or wellbeing NICE guidance emphasises shared decision-making and individualised care
If you or a loved one took a GLP-1 RA like Ozempic and suffered from sudden vision loss (NAION), call us today for a free, no-obligation case evaluation
From gentle brightening peels to hydration therapy, every treatment is personalized for your skins needs
